Delivery Order SPE2DP20D0002-SPE2DP21F2052
Award Date 2/11/21
Potential Completion Date 2/23/21
Potential Value $706K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Parsippany, NJ 07054, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Teva Pharmaceuticals USA, Inc. was awarded a $564,707.52 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The place of performance is Teva's facility located in Parsippany, New Jersey. The delivery order has a period of performance starting on March 10, 2021 through March 23, 2021. No major subcontractors or set aside designations were identified. The DLA supports the Department of Defense by procuring pharmaceuticals and...
- Teva Pharmaceuticals USA, Inc. was awarded a $564,707.52 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The place of performance is Teva's facility located in Parsippany, New Jersey. The delivery order has a period of performance starting on July 13, 2021 through July 20, 2021. No major subcontractors or set aside designations were identified. The DLA supports the Department of Defense by procuring pharmaceuticals and...
- Teva Pharmaceuticals USA, Inc. was awarded a $950,229 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The contract has a period of performance from July 22, 2020 through July 28, 2020, with all work to be completed at Teva's facility in Parsippany, New Jersey. No subcontractors or set aside designations were identified. This delivery order...
- Teva Pharmaceuticals USA, Inc. was awarded a $542,988 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The contract has a period of performance from November 3, 2020 through November 17, 2020, with all work to be completed at Teva's facility in Parsippany, New Jersey. No subcontractors or set aside designations were identified. This delivery...
- Teva Pharmaceuticals USA, Inc. was awarded a $542,988 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The contract was issued under an indefinite-delivery/indefinite-quantity contract vehicle held by DLA for pharmaceutical products. Teva will deliver the adenovirus to its facility located in Parsippany, New Jersey, with performance required between November 3 and November 17, 2020. No subcontractors or set aside...
- Teva Pharmaceuticals USA, Inc. was awarded an $814,482 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The delivery order, issued on July 22, 2020, requires Teva Pharmaceuticals to deliver the requested pharmaceutical product to a location in Parsippany, New Jersey by July 28, 2020. No subcontractors or set aside designations were identified....
- Teva Pharmaceuticals USA, Inc. was awarded a $542,988 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply adenovirus type 4. The contract was issued under an indefinite-delivery/indefinite-quantity medical product contract vehicle held by DLA. Teva will deliver the pharmaceutical product to a location in Parsippany, New Jersey between December 7-15, 2020. No subcontractors or set-aside designations were identified. This award supports DLA's...
- Teva Pharmaceuticals USA, Inc. was awarded an $814,482 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to provide adenovirus type 4 to the Department of Defense. The delivery order, issued on December 7, 2020, calls for Teva to supply the viral product to a location in Parsippany, New Jersey, with completion required by December 15, 2020. No subcontractors or set-aside designations were identified. The...
- The Defense Logistics Agency Troop Support Medical awarded a $705,884 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc. for adenovirus type 4. The place of performance is Teva's facility in Parsippany, New Jersey. The delivery order has a period of performance from February 11, 2021 through February 23, 2021. Teva will deliver the requested adenovirus type 4 to support the Defense Logistics Agency's medical supply chain programs. No subcontractors or set aside designations were...
- Teva Pharmaceuticals USA, Inc. was awarded a $542,988 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to provide adenovirus type 4. The prime contractor will deliver the requested pharmaceutical products to the place of performance in Parsippany, New Jersey by September 29, 2020 in support of DLA's medical supply chain responsibilities. No major subcontractors or set aside designations were indicated. DLA manages the Department of Defense's global...